Literature DB >> 12379748

Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.

Peter W Schlosshauer1, Lora Hedrick Ellenson, Robert A Soslow.   

Abstract

Both beta-catenin and E-cadherin are epithelial cell adhesion molecules. In addition, beta-catenin is an important element of the Wnt signal transduction pathway, which has been implicated in embryogenesis and carcinogenesis, including the development of endometrial and ovarian endometrioid carcinomas. We hypothesized that the expression pattern of these two adhesion molecules may depend upon the histological subtype of endometrial carcinomas. Therefore, we compared the immunohistochemical expression of beta-catenin and E-cadherin in a set of uterine adenocarcinomas matched for high histologic grade, that is, poorly differentiated (International Federation of Gynecology and Obstetrics [FIGO] Grade III) uterine endometrioid carcinomas and uterine serous carcinomas. Seventeen FIGO Grade III endometrioid adenocarcinomas and 17 serous carcinomas were evaluated histologically and immunohistochemically with commercially available monoclonal antibodies against beta-catenin and E-cadherin. Nuclear expression of beta-catenin was observed in 8 of 17 (47%) endometrioid adenocarcinomas but in none of the serous carcinomas (P = .003). Moderate or strong E-cadherin expression was identified in 7 of 17 (41%) serous carcinomas as opposed to in only 1 of 17 (6%) endometrioid adenocarcinomas (P = .02). The majority of endometrioid adenocarcinomas showed strong beta-catenin expression coupled with weak E-cadherin expression; serous carcinomas did not exhibit a comparable trend. Our results indicate that the expression of beta-catenin and E-cadherin in high-grade endometrial cancers is strongly associated with histological subtype. These data provide further support for the distinct molecular profiles of endometrioid adenocarcinoma and serous carcinoma. Notably, differences in cell adhesion molecule expression could account for variations in patterns of tumor dissemination. The immunohistochemical staining pattern may also be useful for diagnostic purposes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379748     DOI: 10.1097/01.MP.0000028573.34289.04

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  29 in total

1.  A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesis.

Authors:  Núria Eritja; David Llobet; Mónica Domingo; Maria Santacana; Andree Yeramian; Xavier Matias-Guiu; Xavi Dolcet
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

2.  Genetic polymorphisms in CDH1 are associated with endometrial carcinoma susceptibility among Chinese Han women.

Authors:  Yue-Hang Geng; Zi-Fan Wang; Yu-Mian Jia; Li-Yuan Zheng; Lan Chen; Dong-Ge Liu; Xiang-Hong Li; Xin-Xia Tian; Wei-Gang Fang
Journal:  Oncol Lett       Date:  2018-09-20       Impact factor: 2.967

Review 3.  The emerging genomic landscape of endometrial cancer.

Authors:  Matthieu Le Gallo; Daphne W Bell
Journal:  Clin Chem       Date:  2013-10-29       Impact factor: 8.327

4.  Significance of p53 expression in background endometrium in endometrial carcinoma.

Authors:  Thuy Thi Nguyen; Toru Hachisuga; Rie Urabe; Tomoko Kurita; Seiji Kagami; Toshinori Kawagoe; Shohei Shimajiri; Kazuki Nabeshima
Journal:  Virchows Arch       Date:  2015-03-19       Impact factor: 4.064

5.  APC and beta-catenin protein expression patterns in HNPCC-related endometrial and colorectal cancers.

Authors:  Reetta Kariola; Wael M Abdel-Rahman; Miina Ollikainen; Ralf Butzow; Päivi Peltomäki; Minna Nyström
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 6.  Personalized therapy in endometrial cancer: challenges and opportunities.

Authors:  Shannon N Westin; Russell R Broaddus
Journal:  Cancer Biol Ther       Date:  2012-01-01       Impact factor: 4.742

7.  Insights into endometrial serous carcinogenesis and progression.

Authors:  Oluwole Fadare; Wenxin Zheng
Journal:  Int J Clin Exp Pathol       Date:  2009-01-10

8.  Controversies in the management of endometrial carcinoma.

Authors:  Ying Zhang; Jian Wang
Journal:  Obstet Gynecol Int       Date:  2010-06-22

9.  The genomics and genetics of endometrial cancer.

Authors:  Andrea J O'Hara; Daphne W Bell
Journal:  Adv Genomics Genet       Date:  2012-03

10.  Application of Immunohistochemistry and Molecular Diagnostics to Clinically Relevant Problems in Endometrial Cancer Bojana Djordjevic, Shannon Westin, Russell R. Broaddus.

Authors:  Bojana Djordjevic; Shannon Westin; Russell R Broaddus
Journal:  Surg Pathol Clin       Date:  2012-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.